Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Diabetic Neuropathy
86%
Prevalence
57%
Patient with Type 2 Diabetes
37%
Neuropathy
36%
Polyneuropathy
35%
Cohort Analysis
26%
Diagnosis
17%
Cardiovascular System
17%
Diabetes
16%
Cardiovascular Disease
15%
Insulin Sensitivity
15%
Cell Function
13%
Patient Registry
12%
Apoplexy
12%
Attributable Risk
12%
Cross Sectional Study
9%
Patient Characteristics
9%
Drug Use
9%
Drug Prescription
9%
Quality of Life
9%
Diabetes Mellitus
8%
Pediatrics
8%
Diabetic Foot
8%
ICD-10
8%
Foot Ulcer
8%
Alendronic Acid
8%
Recurrent Disease
8%
Dapagliflozin
8%
Empagliflozin
8%
Neuropathic Pain
6%
Beta Cell
6%
Congestive Heart Failure
6%
Glucagon-Like Peptide-1 Agonist
5%
Glycon
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Symptom
5%
Diagnosis Code
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
51%
Cohort Study
45%
Diabetic Neuropathy
25%
Statin (Protein)
22%
Prevalence
20%
Venous Thromboembolism
17%
Syndrome
17%
Malignant Neoplasm
17%
Polyneuropathy
17%
Non Insulin Dependent Diabetes Mellitus
17%
Standardized Incidence Ratio
15%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%
Triacylglycerol
12%
Ethanol
11%
Brain Ischemia
9%
Alendronic Acid
9%
Mortality Rate
9%
Liver Cirrhosis
8%
Thyroid Disease
8%
Bisphosphonic Acid Derivative
8%
Hyperthyroidism
8%
Acetylsalicylic Acid
8%
Diabetes Mellitus
8%
Recurrent Disease
8%
Dapagliflozin
8%
Empagliflozin
8%
Cardiovascular Disease
7%
Hypothyroidism
7%
Congestive Heart Failure
7%
Brain Hemorrhage
6%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Glucagon Like Peptide 1 Receptor Agonist
5%
Metformin
5%
Coronary Artery Atherosclerosis
5%
Patient Registry
5%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
17%
Strategic Research
9%
Diabetes Subgroups
8%
Diabetic Neuropathy
8%
Biobank
8%
Incidence Rate
8%
High Incidence
8%
Michigan Neuropathy Screening Instrument
8%
Cohort Profile
8%
Cardiovascular Disease
8%
Denmark
6%
